Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications

Biomaterials

Volumn 26, Issue 7, 2005, Pages 729-738

  Cheng, Fong Yu ^a   Su, Chia Hao ^a   Yang, Yu Sheng ^a   Yeh, Chen Sheng ^a   Tsai, Chiau Yuang ^a   Wu, Chao Liang ^a   Wu, Ming Ting ^a,b,c   Shieh, Dar Bin ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cytotoxicity; MRI; Nanoparticle

Indexed keywords

BIOMEDICAL APPLICATIONS; ELECTROSTATIC INTERACTION; MOLECULAR IMAGING; NANOPARTICLES;

BIOMEDICAL ENGINEERING; COATING TECHNIQUES; ELECTROSTATICS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; IRON OXIDES; NANOSTRUCTURED MATERIALS; NUCLEAR MAGNETIC RESONANCE; PHOTOELECTRON SPECTROSCOPY; POLYMERS; PRECIPITATION (CHEMICAL); SOLUTIONS; SQUIDS; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

DISPERSIONS;

HYDROXIDE; IRON OXIDE; MAGNETITE; NANOPARTICLE; PROTON; SUPERPARAMAGNETIC IRON OXIDE; TETRAMETHYLAMMONIUM; WATER;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; BLOOD; CHEMICAL REACTION; CONTROLLED STUDY; CYTOTOXICITY TEST; DEVICE; DIAGNOSTIC IMAGING; DISPERSION; ELECTRICITY; HUMAN; INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRECIPITATION; PRIORITY JOURNAL; SERUM; STATISTICAL SIGNIFICANCE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMEDICAL ENGINEERING; CERCOPITHECUS AETHIOPS; COLLOIDS; COS CELLS; FERRIC COMPOUNDS; HEMOLYSIS; HUMANS; MATERIALS TESTING; NANOTUBES; PARTICLE SIZE; WATER;

CEPHALOPODA;

EID: 4444292036     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.03.016     Document Type: Article

References (45)

1. Shen L., Laibinis P.E., Hatton T.A. Bilayer surfactant stabilized magnetic fluids. synthesis and interactions at interfaces Langmuir. 15:1999;447-453
2. Sun S., Zeng H. Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc. 124:2002;8204-8205
3. 4 particles. Mater Sci Eng A. 286:2000;101-105
4. 3 particles. Chem Mater. 8:1996;2209-2211
5. Mann S., Hannington J.P. Formation of iron oxides in unilamellar vesicles. J Colloid Interface Sci. 122:1988;326-335
6. Qu S., Yang H., Ren D., Kan S., Zou G., Li D., Li M. Magnetite nanoparticles prepared by precipitation from partially reduced ferric chloride aqueous solutions. J Colloid Interface Sci. 215:1999;190-192
7. Kim D.K., Zhang Y., Voit W., Rao K.V., Muhanned M. Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles. J Magn Magn Mater. 225:2001;30-36
8. Fu L., Dravid V.P., Johnson D.L. Self-assembled(SA) bilayer molecular coating on magnetic nanoparticles. Appl Surf Sci. 181:2001;173-178
9. Zhang Y., Kohler N., Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 23:2002;1553-1561
10. Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, PTGS, Saunders M. Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 2003;15:1367-77.
11. Kim D.K., Zhang Y., Kehr J., Klason T., Bjelke B., Muhammed M. Characterization and MRI study of surfactant-coated superparamagnetic nanoparticles administered into the rat brain. J Magn Magn Mater. 225:2001;256-261
12. Reynolds C.H., Annan N., Beshah K., Huber J.H., Shaber S.H., Lenkinski R.E., Wortman J.A. Gadolinium-loaded nanoparticles. new contrast agents for magnetic resonance imaging J Am Chem Soc. 122:2000;8940-8945
13. Lubbe A.S., Bergemann C., Riess H. Clinical experiences with magnetic drug targeting. a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors Cancer Res. 56:1996;4686-4693
14. Bergemann C., Muller-Schulte D., Oster J., Brassard L., Lubbe A.S. Magnetic ion-exchange nano- and macroparticles for medical, biochemical and molecular biological applications. J Magn Magn Mater. 194:1999;45-52
15. Chan D.C.F., Kirpotin D.B., Bunn P. Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer. J Magn Magn Mater. 122:1993;374-378
16. Jordan A., Scholz R., Wust P., Schirra H., Schiestel T., Schmidt H., Felix R. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J Magn Magn Mater. 194:1999;185-196
17. 3 magnetic nanoparticles. J Am Chem Soc. 125:2003;1684-1685
18. Bean C.P., Livingston J.D. Superparamagnetism. J Appl Phys. 30:1959;120-129
19. Koenig SH, Brown III RD, Relaxometry of magnetic resonance imaging contrast agents. Magn Reson Annu 1987:263-86.
20. Lind K., Kresse M., Debus N.P., Muller R.H. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography. comparison of physicochemical properties and the in vivo behaviour J Drug Target. 10:2002;221-230
21. Bellin M.F., Beigelman C., Precetti-Morel S. Iron oxide-enhanced MR lymphography. initial experience Eur J Radiol. 34:2000;257-264
22. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging. physicochemical characteristics and clinical applications A review. J Drug Target. 6:1998;167-174
23. Muller R.N., Vallet P., Maton F., Roch A., Goudemant J.F., Vander Elst L., Gillis P., Peto S., Moiny F., Van Haverbeke Y. Recent developments in design, characterization, and understanding of MRI and MRS contrast media. Invest Radiol. 25(Suppl 1):1990;S34-S36
24. Weissleder R., Elizondo G., Wittenberg J., Rabito C.A., Bengele H.H., Josephson L. Ultrasmall superparamagnetic iron oxide. characterization of a new class of contrast agents for MR imaging Radiology. 175:1990;489-493
25. Thode K., Luck M., Schroder W., Semmler W., Blunk T., Muller R.H., Kresse M. The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins. J Drug Target. 5:1997;35-43
26. Reimer P., Kwong K.K., Weisskoff R., Cohen M.S., Brady T.J., Weissleder R. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents. J Magn Reson Imaging. 2:1992;177-181
27. Chouly C., Pouliquen D., Lucet I., Jeune J.J., Jallet P. Development of superparamagnetic nanoparticles for MRI. effect of particle size, charge and surface nature on biodistribution J Microencapsul. 13:1996;245-255
28. Reimer P., Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver. properties, clinical development, and applications Eur Radiol. 13:2003;1266-1276
29. Atkinson T.P., Smith T.F., Hunter R.L. In vitro release of histamine from murine mast cells by block co-polymers composed of polyoxyethylene and polyoxypropylene. J Immunol. 141:1988;1302-1306
30. Ennis M., Lorenz W., Gerland W. Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor El (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions Agents Actions. 18:1986;235-238
31. McLachlan S.J., Morris M.R., Lucas M.A., Fisco R.A., Eakins M.N., Fowler D.R., Scheetz R.B., Olukotun A.Y. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging. 4:1994;301-307
32. Nolte H., Carstensen H., Hertz H. VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children. Am J Pediatr Hematol Oncol. 10:1988;308-312
33. Taupitz M., Schnorr J., Abramjuk C., Wagner S., Pilgrimm H., Hunigen H., Hamm B. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography. preclinical results in rats and rabbits J Magn Reson Imaging. 12:2000;905-911
34. Schnorr J., Wagner S., Pilgrimm H., Hamm B., Taupitz M. Preclinical characterization of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as a blood pool contrast medium for MR angiography. Acad Radiol. 9(Suppl 2):2002;S307-S309
35. Wagner S., Schnorr J., Pilgrimm H., Hamm B., Taupitz M. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging. preclinical in vivo characterization Invest Radiol. 37:2002;167-177
36. Taupitz M., Schnorr J., Wagner S., Abramjuk C., Pilgrimm H., Kivelitz D., Schink T., Hansel J., Laub G., Hunigen H., Hamm B. Coronary MR angiography. experimental results with a monomer-stabilized blood pool contrast medium Radiology. 222:2002;120-126
37. Cornell RM, Schwertmann U. The Iron Oxide: Structure, Properties, Reactions, Occurrence and Uses. VCH:1996.
38. Jung C.W. Surface properties of superparamagnetic iron oxide MR contrast agents. ferumoxides, ferumoxtran, ferumoxsil Magn Reson Imaging. 13:1995;675-691
39. Harvey D.T., Linton R.W. Chemical characterization of hydrous ferric oxides by X-ray photoelectron spectroscopy. Anal Chem. 53:1981;1684-1688
40. Finn P., Jolly W.L. The nitrogen 1s binding energies of transition metal nitrosyls. Inorg Chem. 11:1972;893-895
41. Incorvia M.J., Contarini S. X-ray photoelectron spectroscopic studies of metal/inhibitor systems. structure and bonding at the iron/amine interface J Electrochem Soc. 136:1989;2493-2498
42. Closmann C., Krvittle E., Bridges F. An XAFS study of the crystal chemistry of Fe in orthopyroxene. Am Mineral. 81:1996;1321-1331
43. Stark D.D., Weissleder R., Elizondo G., Hahn P.F., Saini S., Todd L.E., Wittenberg J., Ferrucci J.T. Superparamagnetic iron oxide. clinical application as a contrast agent for MR imaging of the liver Radiology. 168:1988;297-301
44. Saini S., Ferrucci J.T. Ferrite particles as an MR contrast agent. Radiology. 169:1988;656
45. Hahn P.F., Stark D.D., Weissleder R., Elizondo G., Saini S., Ferrucci J.T. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology. 174:1990;361-366